Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Clinical trial NCT04745559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04745559
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma (PMBCL)Transformed Follicular Lymphoma (TFL)High-grade B-cell Lymphoma (HGBCL)Follicular Lymphoma

Start date: 2021-02-18
Primary completion: 2025-07-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.